| human | Q5 |
| P496 | ORCID iD | 0000-0001-7675-7569 |
| P27 | country of citizenship | Sweden | Q34 |
| P735 | given name | Annika | Q567094 |
| Annika | Q567094 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | female | Q6581072 |
| Q36016386 | 11q13 is a susceptibility locus for hormone receptor positive breast cancer |
| Q35871567 | 19p13.1 is a triple-negative-specific breast cancer susceptibility locus |
| Q33848895 | 2q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapy |
| Q36021406 | 7q21-rs6964587 and breast cancer risk: an extended case-control study by the Breast Cancer Association Consortium |
| Q37169873 | 9q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: evidence from the Breast Cancer Association Consortium |
| Q35119757 | A frame-shift mutation of PMS2 is a widespread cause of Lynch syndrome |
| Q35760274 | A genome wide linkage analysis in Swedish families with hereditary non-familial adenomatous polyposis/non-hereditary non-polyposis colorectal cancer |
| Q53395693 | A germline E-cadherin mutation in a family with gastric and colon cancer. |
| Q35687702 | A germline variant in the TP53 polyadenylation signal confers cancer susceptibility |
| Q73777232 | A human compound heterozygote for two MLH1 missense mutations |
| Q36108214 | A hypothesis-generating search for new genetic breast cancer syndromes--a national study in 803 Swedish families |
| Q37619303 | A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium |
| Q34433744 | A large-scale meta-analysis to refine colorectal cancer risk estimates associated with MUTYH variants |
| Q44385739 | A naturally occurring mutation in an ATP-binding domain of the recombination repair gene XRCC3 ablates its function without causing cancer susceptibility |
| Q92711687 | A network analysis to identify mediators of germline-driven differences in breast cancer prognosis |
| Q40177742 | A new polymorphism in the coding region of exon four in HSD17B2 in relation to risk of sporadic and hereditary breast cancer |
| Q36152991 | A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriers |
| Q45742284 | A pooled analysis of the outcome of prospective colonoscopic surveillance for familial colorectal cancer |
| Q74340214 | A rare CYP19 (aromatase) variant may increase the risk of breast cancer |
| Q58574407 | A retrospective study of extracolonic, non-endometrial cancer in Swedish Lynch syndrome families |
| Q24794792 | A screen for germline mutations in the gene encoding CCCTC-binding factor (CTCF) in familial non-BRCA1/BRCA2 breast cancer |
| Q73436948 | A screening for BRCA1 mutations in breast and breast-ovarian cancer families from the Stockholm region |
| Q34071175 | A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer |
| Q74268830 | A study of the PTEN/MMAC1 gene in 136 breast cancer families |
| Q24317542 | A widely expressed transcription factor with multiple DNA sequence specificity, CTCF, is localized at chromosome segment 16q22.1 within one of the smallest regions of overlap for common deletions in breast and prostate cancers |
| Q43553459 | APC I1307K and E1317Q variants are rare or do not occur in Swedish colorectal cancer patients |
| Q33335710 | ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma |
| Q71513083 | ATM mutations in cancer families |
| Q35594315 | Adenoma prevalence and cancer risk in familial non-polyposis colorectal cancer |
| Q39437211 | Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers |
| Q51060676 | Ambulatory orthopaedic surgery patient education and cost of care. |
| Q36073563 | An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression |
| Q35618307 | An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers |
| Q33641475 | Ancestry-shift refinement mapping of the C6orf97-ESR1 breast cancer susceptibility locus |
| Q35218520 | Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy |
| Q45979098 | Association analysis identifies 65 new breast cancer risk loci. |
| Q37292963 | Association of ESR1 gene tagging SNPs with breast cancer risk |
| Q91271723 | Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness |
| Q40251952 | Association of adenomatous polyposis coli (APC) gene polymorphisms with autism spectrum disorder (ASD). |
| Q37684672 | Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21. |
| Q37268494 | Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry |
| Q114182713 | Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment |
| Q34129391 | Association studies on 11 published colorectal cancer risk loci |
| Q35022847 | Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies |
| Q35532898 | Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium |
| Q35446668 | BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing |
| Q37261138 | BRCA1 R1699Q variant displaying ambiguous functional abrogation confers intermediate breast and ovarian cancer risk |
| Q38914005 | BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer |
| Q37002955 | BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers |
| Q54653413 | BRCA2 germline mutations in Swedish breast cancer families. |
| Q51575250 | Bioinformatics for human genetics: promises and challenges. |
| Q46115524 | Body mass index and breast cancer survival: a Mendelian randomization analysis |
| Q100457582 | Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk |
| Q34327945 | Breast cancer risk and 6q22.33: combined results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2 |
| Q35940158 | Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170. |
| Q45714428 | CDH1 mutations are present in both ductal and lobular breast cancer, but promoter allelic variants show no detectable breast cancer risk |
| Q33294514 | CHEK2 1100delC is prevalent in Swedish early onset familial breast cancer |
| Q36449203 | CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer |
| Q21261335 | COL11A1 in FAP polyps and in sporadic colorectal tumors |
| Q36419325 | CYP19A1 fine-mapping and Mendelian randomization: estradiol is causal for endometrial cancer |
| Q40221041 | Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database |
| Q55560458 | Cancer occurrence during follow-up of the CAPP2 study -aspirin use for up to four years significantly reduces Lynch syndrome cancers for up to several years after completion of therapy. |
| Q47159601 | Cancer risk susceptibility loci in a Swedish population |
| Q28385765 | Candidate locus analysis of the TERT-CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk |
| Q53474173 | Chromosomal deletions in anaplastic meningiomas suggest multiple regions outside chromosome 22 as important in tumor progression. |
| Q34547579 | Classification of colorectal polyps: guidelines for the endoscopist |
| Q36943290 | Clinicopathological analysis of colorectal cancer: a comparison between emergency and elective surgical cases |
| Q47668909 | Colonoscopy findings in high-risk individuals compared to an average-risk control population |
| Q35782915 | Colorectal cancer as a complex disease: defining at-risk subjects in the general population - a preventive strategy |
| Q42374502 | Colorectal cancer incidence in path_MLH1 carriers subjected to different follow-up protocols: a Prospective Lynch Syndrome Database report |
| Q34358210 | Colorectal cancer susceptibility loci in a population-based study: Associations with morphological parameters |
| Q73031255 | Colorectal cancer with and without microsatellite instability involves different genes |
| Q73933398 | Colorectal carcinogenesis is associated with stromal expression of COL11A1 and COL5A2 |
| Q37368000 | Combined genetic and splicing analysis of BRCA1 c.[594-2A>C; 641A>G] highlights the relevance of naturally occurring in-frame transcripts for developing disease gene variant classification algorithms |
| Q36839777 | Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers |
| Q34394665 | Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction |
| Q34379032 | Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium |
| Q36393232 | Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers |
| Q39901473 | Common variants in human CRC genes as low-risk alleles |
| Q57251792 | Common variants on chromosome 5p12 confer susceptibility to estrogen receptor–positive breast cancer |
| Q34631785 | Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer |
| Q29417133 | Common variation near CDKN1A, POLD3 and SHROOM2 influences colorectal cancer risk |
| Q31082788 | Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC) |
| Q36026731 | Comprehensive genetic assessment of the ESR1 locus identifies a risk region for endometrial cancer |
| Q57287587 | Consortium study on 1280 breast carcinomas: allelic loss on chromosome 17 targets subregions associated with family history and clinical parameters |
| Q93118070 | Correction to: Genetic variant predictors of gene expression provide new insight into risk of colorectal cancer |
| Q57278898 | Correction: Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC) |
| Q37409157 | Cumulative impact of common genetic variants and other risk factors on colorectal cancer risk in 42,103 individuals |
| Q44175923 | Cyclin D2 expression in familial and sporadic breast cancer |
| Q48016528 | DGGE screening of mutations in mismatch repair genes (hMSH2 and hMLH1) in 34 Swedish families with colorectal cancer. |
| Q44837117 | Deciphering the colon cancer genes--report of the InSiGHT-Human Variome Project Workshop, UNESCO, Paris 2010. |
| Q38857512 | Defining New Colorectal Cancer Syndromes in a Population-based Cohort of the Disease |
| Q40513212 | Definition of candidate low risk APC alleles in a Swedish population |
| Q58862219 | Deletions on chromosome 16 in primary familial breast carcinomas are associated with development of distant metastases |
| Q24626852 | Differential expression of aquaporin 8 in human colonic epithelial cells and colorectal tumors |
| Q60472142 | Discovery of common and rare genetic risk variants for colorectal cancer |
| Q42632894 | Distinct patterns of KRAS mutations in colorectal carcinomas according to germline mismatch repair defects and hMLH1 methylation status |
| Q34901055 | Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome |
| Q73490355 | Enhanced detection of mutations in BRCA1 exon 11 using restriction endonuclease fingerprinting-single-strand conformation polymorphism |
| Q57307214 | Erratum: Corrigendum: ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma |
| Q56436255 | Erratum: Corrigendum: Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer |
| Q38319276 | Estrogen receptor beta (ESR2) polymorphisms in familial and sporadic breast cancer |
| Q35288237 | European genome-wide association study identifies SLC14A1 as a new urinary bladder cancer susceptibility gene |
| Q37745041 | Evaluation of copy-number variants as modifiers of breast and ovarian cancer risk for BRCA1 pathogenic variant carriers |
| Q51937804 | Evaluation of psychosocial effects of pre-symptomatic testing for breast/ovarian and colon cancer pre-disposing genes: a 12-month follow-up. |
| Q35653910 | Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk |
| Q35064451 | Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation |
| Q37342144 | Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation |
| Q35922790 | Exome sequencing in one family with gastric- and rectal cancer |
| Q37594336 | FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium |
| Q40466587 | Familial breast cancer and genes involved in breast carcinogenesis. |
| Q36641199 | Familial breast cancer, underlying genes, and clinical implications: a review |
| Q33646157 | Familial cancer among consecutive uterine cancer patients in Sweden |
| Q43843696 | Families with hereditary cancer--a target group for prevention |
| Q54516617 | Family history of colorectal cancer in a Sweden county |
| Q37236216 | Fine scale mapping of the 17q22 breast cancer locus using dense SNPs, genotyped within the Collaborative Oncological Gene-Environment Study (COGs). |
| Q33878276 | Fine scale mapping of the breast cancer 16q12 locus |
| Q36111237 | Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus |
| Q35524465 | Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2. |
| Q61230414 | Fine-mapping of 150 breast cancer risk regions identifies 178 high confidence target genes |
| Q92480972 | Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes |
| Q35063160 | Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk |
| Q39844032 | Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer |
| Q36248936 | Fine-scale mapping of the 4q24 locus identifies two independent loci associated with breast cancer risk |
| Q34903062 | Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1. |
| Q37367871 | Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1. |
| Q58862130 | Finnish mutations in Swedish HNPCC families |
| Q73834609 | First BRCA1 and BRCA2 gene testing implemented in the health care system of Stockholm |
| Q37002930 | Five endometrial cancer risk loci identified through genome-wide association analysis |
| Q34979715 | Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium |
| Q58862231 | Four separate regions on chromosome 17 show loss of heterozygosity in familial breast carcinomas |
| Q33949281 | Frameshift-mutation-derived peptides as tumor-specific antigens in inherited and spontaneous colorectal cancer |
| Q43280944 | Frequent alterations of the PI3K/AKT/mTOR pathways in hereditary nonpolyposis colorectal cancer |
| Q36124728 | Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus |
| Q36742577 | Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers |
| Q57305903 | Further evidence for the contribution of the RAD51C gene in hereditary breast and ovarian cancer susceptibility |
| Q37389405 | Genetic Risk Score Mendelian Randomization Shows that Obesity Measured as Body Mass Index, but not Waist:Hip Ratio, Is Causal for Endometrial Cancer |
| Q115209620 | Genetic analyses of gynecological disease identify genetic relationships between uterine fibroids and endometrial cancer, and a novel endometrial cancer genetic risk region at the WNT4 1p36.12 locus |
| Q108609948 | Genetic insights into biological mechanisms governing human ovarian ageing |
| Q58862199 | Genetic mapping of a second locus predisposing to hereditary non–polyposis colon cancer |
| Q37739048 | Genetic modifiers of CHEK2*1100delC-associated breast cancer risk |
| Q54940815 | Genetic overlap between endometriosis and endometrial cancer: evidence from cross-disease genetic correlation and GWAS meta-analyses. |
| Q35925620 | Genetic predisposition to ductal carcinoma in situ of the breast |
| Q35151684 | Genetic predisposition to in situ and invasive lobular carcinoma of the breast |
| Q58862143 | Genetic rearrangements in sporadic and familial gastric carcinomas detected with microsatellite markers |
| Q63976721 | Genetic variant predictors of gene expression provide new insight into risk of colorectal cancer |
| Q35022825 | Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers |
| Q35179897 | Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study |
| Q34378972 | Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade |
| Q35855955 | Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer |
| Q30000080 | Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent |
| Q28388497 | Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types |
| Q36842233 | Genome-wide association analysis identifies three new breast cancer susceptibility loci |
| Q35996692 | Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer |
| Q24622610 | Genome-wide association studies identify four ER negative-specific breast cancer risk loci |
| Q95329367 | Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses |
| Q64040390 | Genome-wide association study of germline variants and breast cancer-specific mortality |
| Q52839590 | Genome-wide association study yields variants at 20p12.2 that associate with urinary bladder cancer. |
| Q33326484 | Genome-wide linkage scan for colorectal cancer susceptibility genes supports linkage to chromosome 3q. |
| Q73527260 | Germline BRCA1 and HMLH1 mutations in a family with male and female breast carcinoma |
| Q96432094 | Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk |
| Q73892577 | Germline mutation screening of the STK11/LKB1 gene in familial breast cancer with LOH on 19p |
| Q40415679 | Germline mutations in the MYH gene in Swedish familial and sporadic colorectal cancer |
| Q114182677 | Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis |
| Q36276540 | Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization |
| Q58862257 | Hereditary breast cancer in sweden: a predominance of maternally inherited cases |
| Q34019583 | Hereditary breast cancer: a review |
| Q72046532 | High allele loss rates at 17q12-q21 in breast and ovarian tumors from BRCAl-linked families. The Breast Cancer Linkage Consortium |
| Q43073417 | High incidence of skewed X chromosome inactivation in young patients with familial non-BRCA1/BRCA2 breast cancer |
| Q35058184 | How to catch all those mutations--the report of the third Human Variome Project Meeting, UNESCO Paris, May 2010. |
| Q36417829 | Hyperplastic polyposis coli syndrome and colorectal carcinoma |
| Q35102646 | Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk |
| Q36859142 | Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer |
| Q36086247 | Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus |
| Q57170142 | Identification of nine new susceptibility loci for endometrial cancer |
| Q34048230 | Identification of susceptibility loci for colorectal cancer in a genome-wide meta-analysis |
| Q46103372 | Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer |
| Q36674459 | Immunohistochemical Loss of the DNA Mismatch Repair Proteins MSH2 and MSH6 in Malignant Fibrous Histiocytomas |
| Q40719336 | Incidence of and survival after subsequent cancers in carriers of pathogenic MMR variants with previous cancer: a report from the prospective Lynch syndrome database |
| Q47672861 | Individuals with an increased risk of colorectal cancer: perceived benefits and psychological aspects of surveillance by means of regular colonoscopies |
| Q35104068 | Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer |
| Q53431648 | Ki-ras mutations and prognosis in colorectal cancer. |
| Q34194324 | Lack of HIN-1 methylation in BRCA1-linked and "BRCA1-like" breast tumors. |
| Q57319833 | Lack of an Association between the TGFBR1*6A Variant and Colorectal Cancer Risk |
| Q29416989 | Large-scale genotyping identifies 41 new loci associated with breast cancer risk |
| Q43170770 | Linkage analysis in a large Swedish family supports the presence of a susceptibility locus for adenoma and colorectal cancer on chromosome 9q22.32-31.1. |
| Q35071116 | Linkage analysis in familial non-Lynch syndrome colorectal cancer families from Sweden |
| Q35194225 | Linkage analysis with markers on 17q in 29 Swedish breast cancer families |
| Q35000837 | Linkage to chromosome 2q32.2-q33.3 in familial serrated neoplasia (Jass syndrome). |
| Q54608084 | Long-range PCR facilitates the identification of PMS2-specific mutations. |
| Q35627411 | Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial |
| Q56435837 | Long-term effect of resistant starch on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial |
| Q58862210 | Loss of heterozygosity in familial breast carcinomas |
| Q58862149 | Loss of heterozygosity studies in tumors from families with breast-ovarian cancer syndrome |
| Q57741871 | Loss of mismatch repair protein immunostaining in colorectal adenomas from patients with hereditary nonpolyposis colorectal cancer |
| Q24796546 | Low frequency of E-cadherin alterations in familial breast cancer |
| Q73081870 | Low frequency of hMSH2 mutations in Swedish HNPCC families |
| Q35119701 | Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium |
| Q57741862 | Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer) Diagnostics |
| Q74450981 | MSH2 codon 322 Gly to Asp seems not to confer an increased risk for colorectal cancer susceptibility |
| Q54016777 | MSH6 and MSH3 are rarely involved in genetic predisposition to nonpolypotic colon cancer. |
| Q35940633 | MSI test to distinguish between HNPCC and other predisposing syndromes -- of value in tailored surveillance |
| Q73541254 | Mechanism of diarrhea in collagenous colitis |
| Q56089167 | Mendelian randomisation study of age at menarche and age at menopause and the risk of colorectal cancer |
| Q36333368 | Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1. |
| Q34988292 | Meta-analysis of mismatch repair polymorphisms within the cogent consortium for colorectal cancer susceptibility |
| Q34497352 | MicroRNA related polymorphisms and breast cancer risk |
| Q73757902 | Microsatellite Instability and hMLH1 and hMSH2 expression analysis in familial and sporadic colorectal cancer |
| Q57741879 | Microsatellite instability analysis and/or immunostaining for the diagnosis of hereditary nonpolyposis colorectal cancer? |
| Q42112990 | Microsatellite instability and mismatch repair gene inactivation in sporadic pancreatic and colon tumours |
| Q73189640 | Microsatellite instability as a predictor of a mutation in a DNA mismatch repair gene in familial colorectal cancer |
| Q36619549 | Microsatellite instability in sporadic colorectal cancer is not an independent prognostic factor |
| Q39416577 | Mismatch repair gene mutation spectrum in the Swedish Lynch syndrome population |
| Q73274294 | Missense mutations in hMLH1 associated with colorectal cancer |
| Q34123806 | Missense variants in ATM in 26,101 breast cancer cases and 29,842 controls |
| Q33594249 | Mixed lineage kinase 3 gene mutations in mismatch repair deficient gastrointestinal tumours |
| Q36897003 | Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer |
| Q32028100 | Mutation analyses of KRAS exon 1 comparing three different techniques: temporal temperature gradient electrophoresis, constant denaturant capillary electrophoresis and allele specific polymerase chain reaction |
| Q28237756 | Mutation analysis of the DBC2 gene in sporadic and familial breast cancer |
| Q58862127 | Mutation screening in the hMLH1 gene in Swedish hereditary nonpolyposis colon cancer families |
| Q24615109 | New common variants affecting susceptibility to basal cell carcinoma |
| Q37356243 | Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. |
| Q30374367 | No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. |
| Q37079859 | No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing |
| Q28211127 | No mutations in the BACH1 gene in BRCA1 and BRCA2 negative breast-cancer families linked to 17q22 |
| Q56359054 | Novel Common Genetic Susceptibility Loci for Colorectal Cancer |
| Q46538007 | Obesity, Aspirin, and Risk of Colorectal Cancer in Carriers of Hereditary Colorectal Cancer: A Prospective Investigation in the CAPP2 Study |
| Q36280191 | Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers |
| Q28584533 | PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS |
| Q47143943 | PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1. |
| Q38897294 | Parent of Origin and Prognosis in Familial Breast Cancer in Sweden |
| Q34289136 | Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche |
| Q112572520 | Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes |
| Q37307937 | Patient survival and tumor characteristics associated with CHEK2:p.I157T - findings from the Breast Cancer Association Consortium |
| Q62583133 | Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes |
| Q36066735 | Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression |
| Q92055460 | Prediction and clinical utility of a contralateral breast cancer risk model |
| Q36583004 | Prediction of breast cancer risk based on profiling with common genetic variants |
| Q91832507 | Prediction of contralateral breast cancer: external validation of risk calculators in 20 international cohorts |
| Q35889351 | Predisposition for breast cancer in carriers of constitutional translocation 11q;22q |
| Q47238239 | Preoperative psychological reactions and quality of life among women with an increased risk of breast cancer who are considering a prophylactic mastectomy |
| Q35595893 | Prevalence and incidence of hyperplastic polyps and adenomas in familial colorectal cancer: correlation between the two types of colon polyps |
| Q37103047 | Prevalence of adenomas and hyperplastic polyps in mismatch repair mutation carriers among CAPP2 participants: report by the colorectal adenoma/carcinoma prevention programme 2. |
| Q43558829 | Psychological reactions, quality of life, and body image after bilateral prophylactic mastectomy in women at high risk for breast cancer: a prospective 1-year follow-up study |
| Q55508030 | Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation. |
| Q90242034 | Publisher Correction: Shared heritability and functional enrichment across six solid cancers |
| Q36009422 | RAD51B in Familial Breast Cancer |
| Q74319733 | Re: Dominant negative ATM mutations in breast cancer families |
| Q44742265 | Recommendations of the 2006 Human Variome Project meeting |
| Q52652189 | Recurrent, low-frequency coding variants contributing to colorectal cancer in the Swedish population. |
| Q35155449 | Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia |
| Q38882556 | Regulator of Chromosome Condensation 2 Identifies High-Risk Patients within Both Major Phenotypes of Colorectal Cancer |
| Q51768089 | Report of the combined meeting of the International Society for Gastrointestinal Hereditary Tumours, the Human Variome Project and the National Cancer Institute Colon Cancer Family Registry, Duesseldorf, Germany, 24 June 2009. |
| Q45951126 | Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study. |
| Q24618618 | Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability |
| Q36824964 | Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts |
| Q37348988 | Risk perception after genetic counseling in patients with increased risk of cancer |
| Q43075147 | Screening families with endometrial and colorectal cancers for germline mutations |
| Q36420172 | Screening for TP53 mutations in patients and tumours from 109 Swedish breast cancer families |
| Q43045153 | Screening for genomic rearrangements of the MMR genes must be included in the routine diagnosis of HNPCC. |
| Q35167887 | Screening for germline phosphatase and tensin homolog-mutations in suspected Cowden syndrome and Cowden syndrome-like families among uterine cancer patients |
| Q73196800 | Screening of 229 family cancer patients for a germline estrogen receptor gene (ESR) base mutation |
| Q71953352 | Sequence variability of a prolonged tetranucleotide repeat |
| Q35964294 | Sequence variant on 8q24 confers susceptibility to urinary bladder cancer |
| Q61118451 | Shared heritability and functional enrichment across six solid cancers |
| Q64004349 | Shared heritability and functional enrichment across six solid cancers |
| Q57741865 | Somatic BRAF-V600E Mutations in Familial Colorectal Cancer |
| Q58862156 | Sublocalization of a locus at 3p21.3?23 predisposing to hereditary nonpolyposis colon cancer |
| Q53670145 | Suspected HNPCC and Amsterdam criteria II: evaluation of mutation detection rate, an international collaborative study. |
| Q37228468 | TGFBR1 variants TGFBR1(*)6A and Int7G24A are not associated with an increased familial colorectal cancer risk |
| Q36611450 | TGFBR1(*)6A and Int7G24A variants of transforming growth factor-beta receptor 1 in Swedish familial and sporadic breast cancer |
| Q33566957 | TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer |
| Q57741875 | The BRCA1 exon 13 duplication in the Swedish population |
| Q49817640 | The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity. |
| Q35151813 | The MLH1 c.1852_1853delinsGC (p.K618A) variant in colorectal cancer: genetic association study in 18,723 individuals |
| Q35781316 | The SNP rs6500843 in 16p13.3 is associated with survival specifically among chemotherapy-treated breast cancer patients |
| Q57741867 | The added value of PMS2 immunostaining in the diagnosis of hereditary nonpolyposis colorectal cancer |
| Q34019570 | The biology of inherited cancer. |
| Q24655454 | The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations |
| Q41642720 | The effect of genotypes and parent of origin on cancer risk and age of cancer development in PMS2 mutation carriers |
| Q54471120 | The estrogen receptor alpha C975G variant in familial and sporadic breast cancer: a case-control study. |
| Q40733621 | The gynecological surveillance of women with Lynch syndrome in Sweden |
| Q44628695 | The reliability of immunohistochemistry as a prescreening method for the diagnosis of hereditary nonpolyposis colorectal cancer (HNPCC)--results of an international collaborative study |
| Q35024008 | The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing |
| Q74427903 | The role of ataxia-telangiectasia heterozygotes in familial breast cancer |
| Q36142060 | The role of genetic breast cancer susceptibility variants as prognostic factors |
| Q53380420 | The role of hMLH3 in familial colorectal cancer |
| Q73647270 | The use of intragenic polymorphisms in determination of the genomic relevance of whole-exon deletions in MLH1 and MSH2 |
| Q36394252 | The use of telephone in genetic counseling versus in-person counseling: a randomized study on counselees' outcome |
| Q28215031 | Tumor-associated zinc finger mutations in the CTCF transcription factor selectively alter tts DNA-binding specificity |
| Q58862098 | Tumorigenesis in colorectal tumors from patients with hereditary non-polyposis colorectal cancer |
| Q35747645 | Tumour spectrum in non-BRCA hereditary breast cancer families in Sweden |
| Q35082686 | Variants of the PPARD gene and their clinicopathological significance in colorectal cancer |
| Q73015976 | Various mutation screening techniques in the DNA mismatch repair genes hMSH2 and hMLH1 |
| Q40367632 | Virtual reality colonoscopy simulation: a compulsory practice for the future colonoscopist? |
| Q72226479 | [Experiences from a clinic for patients with hereditary cancer. Diagnosis of genetic carriers may prevent cancer] |
| Q52887778 | [Nobody will be punished for one's own hereditary disposition. Genetic information should be protected by law] |
| Q72519072 | [The first breast cancer gene isolated. Safer risk assessment for affected families] |
Search more.